Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642219/
http://dx.doi.org/10.1007/s40278-021-06327-9
_version_ 1784609646631190528
collection PubMed
description
format Online
Article
Text
id pubmed-8642219
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-86422192021-12-06 Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador Reactions Weekly Clinical Study Springer International Publishing 2021-12-04 2021 /pmc/articles/PMC8642219/ http://dx.doi.org/10.1007/s40278-021-06327-9 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador
title Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador
title_full Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador
title_fullStr Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador
title_full_unstemmed Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador
title_short Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador
title_sort adverse reactions with pfizer/biontech's covid-19 vaccine in ecuador
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642219/
http://dx.doi.org/10.1007/s40278-021-06327-9

Ejemplares similares